Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach
- PMID: 22409904
- PMCID: PMC3337793
- DOI: 10.1186/1749-8090-7-21
Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach
Abstract
Left Ventricular Assist Device (LVAD) for Destination Therapy (DT) is an established therapy for end stage heart failure patients who are not transplant candidates. Many DT patients requiring LVADs have had prior open heart surgery, the majority of whom had prior sternotomy. In addition, DT patients tend to be older and more likely to have more significant co-morbidities than their Bridge-To-Transplant (BTT) counterparts. As such, placement of an implantable LVAD in DT patients can be technically hazardous and potentially prone to more perioperative complications. The purpose of this report is to describe an alternative implantation approach for the implantation of the Heartmate II™ LVAD in high risk DT patients.
Figures
Similar articles
-
Heartmate II™ device placement five years following ACORN CorCap™ device implantation.J Card Surg. 2012 Mar;27(2):264-5. doi: 10.1111/j.1540-8191.2011.01415.x. Epub 2012 Feb 28. J Card Surg. 2012. PMID: 22372872
-
Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030. Ann Thorac Surg. 2008. PMID: 18805167
-
Robotic Left Ventricular Assist Device Implantation Using Left Thoracotomy Approach in Patients with Previous Sternotomies.ASAIO J. 2015 Nov-Dec;61(6):e44-6. doi: 10.1097/MAT.0000000000000251. ASAIO J. 2015. PMID: 25914953
-
Perioperative Management of the Patient With a Left Ventricular Assist Device for Noncardiac Surgery.Anesth Analg. 2018 Jun;126(6):1839-1850. doi: 10.1213/ANE.0000000000002669. Anesth Analg. 2018. PMID: 29200070 Review.
-
Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.J Card Surg. 2010 Jul;25(4):490-4. doi: 10.1111/j.1540-8191.2010.01075.x. J Card Surg. 2010. PMID: 20642766 Review.
Cited by
-
Minimally-invasive LVAD Implantation: State of the Art.Curr Cardiol Rev. 2015;11(3):246-51. doi: 10.2174/1573403x1103150514151750. Curr Cardiol Rev. 2015. PMID: 25981314 Free PMC article. Review.
-
Life-saving devices reach the end of life with heart failure.Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):274-81. doi: 10.1016/j.pcad.2012.10.007. Prog Cardiovasc Dis. 2012. PMID: 23217431 Free PMC article. Review.
-
Ventricular assist devices implantation: surgical assessment and technical strategies.Cardiovasc Diagn Ther. 2021 Feb;11(1):277-291. doi: 10.21037/cdt-20-325. Cardiovasc Diagn Ther. 2021. PMID: 33708499 Free PMC article. Review.
-
Resternotomy does not adversely affect outcome after left ventricular assist device implantation.Eur J Med Res. 2017 Nov 15;22(1):46. doi: 10.1186/s40001-017-0289-2. Eur J Med Res. 2017. PMID: 29141690 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials